Sarepta Therapeutics (SRPT) Said to Price $300M at $59.75 - Feurstein

September 22, 2016 5:38 PM EDT

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Sarepta Therapeutics (NASDAQ: SRPT) offering 4-5x oversubscribed, offering $300 million at $59.75, Adam Feurstein tweets citing a source.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings, FDA, Momentum Movers, Trader Talk

Related Entities

Adam Feuerstein

Add Your Comment